Mesh-type flexible tip (MFT) catheter is developed to generate bigger radiofrequency (RF) lesion, and contract force (CF) catheter improves the maintenance of catheter-tissue contact during atrial fibrillation catheter ablation (AFCA). The investigators compared clinical outcome of AFCA conducted by MFT catheter and CF catheter in prospective randomized manner. The investigators prospectively assigned 230 patients with AF in a 1:1 ratio to ablation by MFT catheter (FlexAbility™, Abbott Inc. USA) and CF catheter (TactiCath™, Abbott Inc. USA). The primary end point was AF recurrence after single procedure, and the secondary end point was response to antiarrhythmic drugs.
A. Study design 1. Prospective randomization (FlexAbility group vs. TactiCath group ) 2. Target number of subjects: 360 (180 per group) 3. Rhythm follow-up : 2012 ACC/AHA/ESC guidelines (Holter monitoring at the baseline, 2 month, and thereafter every 6 months; ECG if the patient has any symptom) 4. Anticoagulant therapy followed by 2014 ACC/AHA/ESC guidelines 5. All complications in each group will be evaluated including the re-hospitalization rate, cardioversion frequency, major cardiovascular event, and mortality rate. B. Progress and rhythm/ECG follow-up 1. To be performed in accordance with the 2012 ACC/AHA/HRS guidelines for AF management 2. Follow-up at 2 weeks, 2 months, and thereafter every 6-month. 3. Rhythm control at 2 months, and thereafter every 6-month follow-up with Holter 4. If the patient complains of symptoms, ECG will be performed at any time, and rhythm follow-up will be carried out with a Holter or event recorder.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
360
1. AF catheter ablation (PV isolation and linear ablations) 2. 30 sec ablation in each point 3. 35W in anterior LA, 30 W in posterior LA 4. Irrigation flow rate 13mL/min 5. Measuring procedure time, Ablation time 6. Rhythm follow-up based on guidelines
1. AF catheter ablation (PV isolation and linear ablations) 2. contact force \>10g, target force-time integral 400 in each point 3. 35W in anterior LA, 30 W in posterior LA 4. Irrigation flow rate 15mL/min at 30W ablation, 30mL/min at 35W ablation 5. Measuring procedure time, Ablation time 6. Rhythm follow-up based on guidelines
Severance Cardiovascular Hospital, Yonsei University Health System
Seoul, South Korea
procedure related complication rate - open heart surgery, stroke, pericardial tamponade, groin complication, and other procedure related complications within a month
Time frame: 1 month after the procedure
clinical recurrence rate of AF or AT lasting > 30s. Regular rhythm follow-up based on 2012 ACC/AHA/HRS guidelines
Time frame: 12 months after the procedure
clinical recurrence rate of AF or AT lasting > 30s. Regular rhythm follow-up based on 2012 ACC/AHA/HRS guidelines
Time frame: 24 months after the procedure
Major cardiovascular events - death, myocardial infarction, coronary angioplasty, stroke, arrhythmia or heart failure related admission
Time frame: 12 months after the procedure
Major cardiovascular events - death, myocardial infarction, coronary angioplasty, stroke, arrhythmia or heart failure related admission
Time frame: 24 months after the procedure
procedure time
Time frame: intraoperative
RF energy delivery time
Time frame: within 30 minutes after the procedure
volume of irrigated saline infusion
Time frame: within 30 minutes after the procedure
post-procedural readmission rate
Time frame: 12 months after the procedure
post-procedural readmission rate
Time frame: 24 months after the procedure
post-procedural cardioversion rate
Time frame: 12 months after the procedure
post-procedural cardioversion rate
Time frame: 24 months after the procedure
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.